Clinical Drug Investigation

Cost Effectiveness of Controlled-Release Oxybutynin Compared with Immediate-Release Oxybutynin and Tolterodine in the Treatment of Overactive Bladder in the UK, France and Austria
pp. 305-321(17)
Authors: Guest J.F.; Abegunde D.; Ruiz F.J.

Lack of Interaction between Modified-Release Fluvastatin and Amlodipine in Healthy Subjects
pp. 323-331(9)
Authors: Prasad P.P.; Stypinski D.; Vyas K.H.; Gonasun L.

Weekly Oral Alendronic Acid in Male Osteoporosis
pp. 333-341(9)
Authors: Miller P.D.; Schnitzer T.; Emkey R.; Orwoll E.; Rosen C.; Ettinger M.; Vandormael K.; Daifotis A.

Medical Outcomes of Glaucoma Therapy from a Nationwide Representative Survey
pp. 343-352(10)
Authors: Denis P.; Lafuma A.; Berdeaux G.

Randomised, Double-Blind, Parallel, Placebo-Controlled Study of Oral Glucosamine, Methylsulfonylmethane and their Combination in Osteoarthritis
pp. 353-363(11)
Authors: Usha P.R.; Naidu M.U.R.

Improvement in Discomfort and Decreased Blood Flow Associated with Severe Arterial Wall Calcification following Etidronic Acid
pp. 365-371(7)
Authors: Mizuno M.; Kashima N.; Kato K.; Ito A.; Matsuo S.